Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR55 CEUS for Ovarian Lesion Characterization
NCT03493464Phase 2Terminated
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Dec 2018
- Primary completion
- Apr 2021
- Modality
- Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of perfluorobutane/nitrogen lipopeptide-coated microbubbles in ovarian cancer, sponsored by Bracco Diagnostics Inc.. Started Dec 2018; status: terminated.
02
Drugs
perfluorobutane/nitrogen lipopeptide-coated microbubbles
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT03493464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03493464.